原発性肝がんに腹水、黄疸、遠隔転移などを伴う場合を進行原発肝がんといいます。進行原発肝がんの治療は難しく、臨床治療効果も理想的ではありません。進行肝がんはリンパ節や他の臓器に転移しているため、手術は治療の選択肢ではありません。
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the 免疫療法 drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced 肝臓がん. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
